Jim Cramer: 'Go For' AST SpaceMobile, Power Plant Maker 'Too Speculative'
Medline MDLN | 0.00 | |
AST SPACEMOBILE INC ASTS | 0.00 | |
NuScale Power SMR | 0.00 | |
GE Vernova Inc. GEV | 0.00 |
On CNBC’s “Mad Money Lightning Round,” Jim Cramer said he likes Medline Inc. (NASDAQ:MDLN), adding that it is “probably the best IPO of the year.”
Medline announced that it will report second-quarter financial results on Wednesday, Aug. 5. Analysts expect the company to report quarterly earnings at 32 cents per share on revenue of $7.52 billion.
AST SpaceMobile, Inc. (NASDAQ:ASTS) is a “great speculative” stock, Cramer said. “I think you can make money in two years. I would go for it.”
The company announced on June 23 that its next three BlueBird satellites are scheduled to launch in the first half of August, expanding its space-based cellular broadband network.
AST SpaceMobile announced Tuesday that BlueBird satellites 11, 12, and 13 are targeted to launch aboard a Falcon 9 rocket from Cape Canaveral, Florida, in the first half of August.
Cramer said NuScale Power Corporation (NYSE:SMR) is “too speculative” for him, adding that he likes GE Vernova Inc. (NYSE:GEV) as it is safer.
NuScale Power announced it will host a conference call to review second-quarter results on Wednesday, Aug. 5. Analysts expect the company to report a quarterly loss of 13 cents per share on revenue of $14.71 million.
Price Action
- Nuscale Power shares gained 1.2% to settle at $10.15 on Wednesday.
- Medline shares gained 5.8% to close at $41.73.
- AST SpaceMobile shares fell 3.1% to settle at $86.10.
Photo via Shutterstock